Procter & Gamble Co (PG) Stock Price & Analysis
Procter & Gamble Co (PG) rose 1.05% to USD 147.41 as of July 25, 2026 at 01:12 UTC, according to Nexqual real-time market data.
PG last closed at USD 145.88; the session ranged USD 145.4–147.96 on volume of 4,985,343 shares. Market capitalization is —, with a 52-week range of USD 137.62–167.25 (NYQ). Source: Nexqual, July 25, 2026 at 01:12 UTC.
Key Statistics (as of July 25, 2026 at 01:12 UTC)
| Price | USD 147.41 |
|---|---|
| Change | ▲ 1.05% (up) |
| Previous Close | USD 145.88 |
| Open | USD 146.45 |
| Day Range | USD 145.4 – 147.96 |
| 52-Week Range | USD 137.62 – 167.25 |
| Volume | 4,985,343 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (PG)
Nexqual's technical model rates PG "NEUTRAL" based on 2 bullish and 3 bearish signals across 125 daily candles, as of July 25, 2026 at 01:12 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 48.52 (neutral) |
| vs SMA50 | Above (USD 146.9) |
| MACD | 0.1 (positive) |
Analyst Ratings (PG)
Wall Street analysts rate PG "Buy" based on 23 analysts, with a mean price target of USD 163.61 (range USD 145–186), per Nexqual as of July 25, 2026 at 01:12 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 23 |
| Mean Target | USD 163.61 |
| High Target | USD 186 |
| Low Target | USD 145 |
| Buy / Hold / Sell | 15 / 10 / 0 |
Earnings (PG)
| Next Earnings Date | 2026-07-29 |
|---|---|
| EPS Estimate | USD 1.41 |
| Revenue Estimate | $21.38B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 1.59 vs est 1.56 ▲ beat |
| 2025-12-31 | USD 1.88 vs est 1.86 ▲ beat |
| 2025-09-30 | USD 1.99 vs est 1.9 ▲ beat |
| 2025-06-30 | USD 1.48 vs est 1.42 ▲ beat |
Source: Nexqual, July 25, 2026 at 01:12 UTC.
Financials & Fundamentals (PG)
| Total Revenue | $86.72B |
|---|---|
| Revenue Growth (YoY) | +7.40% |
| Gross Margin | +50.98% |
| Operating Margin | +23.05% |
| Profit Margin | +19.16% |
| ROE | +31.11% |
| Debt / Equity | 67.65 |
| Current Ratio | 0.73 |
| Total Cash | $12.31B |
| Total Debt | $37.03B |
| Free Cash Flow | $12.73B |
Source: Nexqual, July 25, 2026 at 01:12 UTC.
Financial Health Score (PG)
Nexqual rates Procter & Gamble Co's overall financial health "Solid" across five dimensions, as of July 25, 2026 at 01:12 UTC.
| Growth | Solid — Revenue +7% YoY (latest Q) |
|---|---|
| Profitability | Strong — Gross margin 51%, operating 23% |
| Balance Sheet | Mixed — $12.3B cash vs $37.0B debt |
| Cash Flow | Solid — FCF $12.7B, 15% margin |
| Efficiency | Strong — ROE 31%, ROA 10.9% |
Ownership (PG)
| Insider Ownership | +0.07% |
|---|---|
| Institutional Ownership | +71.82% |
| Float | 2.32B |
| Short % of Float | +1.03% |
Source: Nexqual, July 25, 2026 at 01:12 UTC.
Leadership (PG)
Procter & Gamble Co is led by Shailesh G. Jejurikar (age 57), CEO, President & Director, per Nexqual as of July 25, 2026 at 01:12 UTC.
| CEO, President & Director | Shailesh G. Jejurikar (age 57) |
|---|---|
| Executive Chairman | Jon R. Moeller (age 61) |
| Chief Financial Officer | Andre Schulten (age 54) |
| Senior Vice President of Investor Relations | John T. Chevalier |
| President of North America & Chief Sales Officer | Melinda Sherwood (age 58) |
Major Backers & Investors (PG)
Notable institutional backers of Procter & Gamble Co include Morgan Stanley, Charles Schwab Investment Management, Inc., JPMorgan, according to Nexqual as of July 25, 2026 at 01:12 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Morgan Stanley | 2.11% |
| Charles Schwab Investment Management, Inc. | 1.78% |
| JPMorgan | 1.43% |
| Price (T.Rowe) Associates Inc | 1.38% |
| FMR, LLC | 1.32% |
| Fidelity | 1.28% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 17.34% |
| BlackRock | 9.34% |
| State Street | 5.56% |
| Geode Capital | 2.77% |
Source: Nexqual, July 25, 2026 at 01:12 UTC.
From Procter & Gamble Co's Latest SEC 10-K Filing (filed 2025-08-04)
Key Strengths & Strategy (as disclosed to the SEC)
- The Procter & Gamble Company provides branded consumer packaged goods worldwide.
- It operates through Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care segments.
- The company offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; antiperspirants, deodorants, and personal cleansing products under the Native, Old Spice, Safeguard, and Secret brands; and facial moisturizers, cleaners, and treatments under the Olay and SK-II brands.
- It also provides blades, razors, shave products, appliances, and other grooming products under the Braun, Gillette, and Venus brands.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| JNJ | Johnson & Johnson | USD 263.4 | ▲ 3.04% |
| KO | Coca-Cola Company (The) | USD 82.25 | ▲ 0.06% |
| MRK | Merck & Company, Inc. | USD 131.07 | ▲ 2.82% |
| HD | Home Depot, Inc. (The) | USD 332.98 | ▲ 0.46% |
| VZ | Verizon Communications Inc. | USD 46.38 | ▲ 4.72% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 01:12 UTC. This page is informational and not investment advice.